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This study aimed to screen the target miRNAs and to investigate the differential miR-3557/324-targeted signal mechanisms in the
rats’ model of Parkinson’s disease (PD) with regular aerobic exercise. Rats were divided into sedentary control PD group (SED-
PD, n = 18) and aerobic exercise PD group (EX-PD, n = 22). After 8 weeks of regular aerobic exercise, a 6-hydroxydopamine-
(6-OHDA-) induced PD lesion model was constructed. Preregular aerobic exercises enhanced the injury resistance of rats with
6-OHDA-induced PD. The rotational behavior after injection of apomorphine hydrochloride was alleviated. Under the scanning
electron microscopy, we found the neurons, axons, and villi of the striatum were clearly and tightly arranged, and neurons and
axons significantly becoming larger. Tyrosine hydroxylase (TH) was increased significantly and 𝛼-synuclein protein expression
was reduced in the EX-PD group compared to the SED-PD group. Screening from miRNA microarray chip, we further found
upregulation of miR-3557 and downregulation of miR-324 were closely related to the calcium-modulating signaling pathway,
remitting the progress of Parkinson’s disease on aerobic exercise. Compared to the SED-PD group, Ca2+/calmodulin dependent
protein kinase II (CaMK2𝛼) was upregulated, but CaMKV and voltage-dependent anion-selective channel protein 1 (Vdac1)
were significantly downregulated in the EX-PD group. Additionally, phosphatidylinositol-3-kinase (PI3K)/mammalian target of
rapamycin (mTOR) expression were activated, and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) expression was upregulated
in the EX-PD group. Conclusions: the adaptive mechanism of regular aerobic exercise delaying neurodegenerative diseases and
lesions was that miR-3557/324 was activated to regulate one of its targets CaMKs signaling pathways. CaMKs, coordinated with
mTOR pathway-related gene expression, improved UCH-L1 level to favor for delaying neurodegeneration or improving the
pathogenesis of PD lesions.
1. Introduction
microRNAs (miRNAs or miR) are associated with various
diseases, such as neurodegenerative diseases [Alzheimer’s
disease (AD), Parkinson’s disease (PD), and Schizophrenia]
[1], cardiovascular diseases (myocardial infarction, myocar-
dial fibrosis, and atherosclerosis) [2], and metabolic dis-
eases (diabetes and obesity) [3]. In the present study
on the miRNAs, about 70% miRNAs were expressed in
the brain tissue of mammals, such as specific miR-124a,
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miRNA-128, and miRNA-101. miRNAs were rich in brain
tissues (such as miR-125b) and important in the regulation
of gene expression in different physiological processes and
signaling pathways of the nervous system, such as the devel-
opment and progression of the nervous system, neural stem
cell differentiation, and apoptosis [4]. Liu et al. [5] reported
that Drosophila melanogaster began to express miR-34 in
its brain in the adulthood and that if miR-34 was missing,
protein misfolding increased, neurodegenerative diseases of
the brain occurred, and the life expectancy was shortened.
In addition, miRNAs may also participate in the occur-
rence of neurodegenerative diseases through some specific
molecular mechanisms. Nelson et al. [6] found that miR-
25 downregulated the expression of synaptic proteins in the
brain of patients with AD and synergized with activated
reactive oxygen species (ROS). Wang et al. [7] reported
that miR-34a could induce neuronal apoptosis by inhibiting
B-cell lymphoma 2 (Bcl-2) in neuronal development and
senescence and that miR-34a was expressed in patients with
AD. Lemaitre et al. [8] showed that the expression of miR-
433 decreased and the expression of fibroblast growth factor
20 (FGF20) increased in patients with PD, while FGF20
promoted the expression of 𝛼-synuclein, which is the most
critical protein in PD pathogenesis. Packer et al. [9] found
that the expression of miR-9 decreased in patients with
PD patients, which might be involved in the pathogen-
esis of PD by modulating the target gene RE1-Silencing
Transcription factor (REST)/coREST. miR-133 regulated the
expression of transcription factorN-myc downregulated gene
1 (NGRG1) associated with PD; miR-7, miR-153, and miR-
433 regulated the expression of 𝛼-synuclein in PD [10].
Dostie et al. [11] showed that miR-175 was associated with
early clinical manifestations of PD. miR-132 and miR-212
were involved in the occurrence of various abnormalities,
such as synaptic plasticity and connectivity in schizophrenia
[12].
Yet, no known study has examined how the miRNAs
(examined via miRNAs profiling) might differ between PD
animals who regularly exercise interventions vs. PD ani-
mals who are habitually sedentary. A study of this type is
needed to discern whether miRNAs can be employed as
a biomarker of neuronal functional decline and whether
regular exercise may more greatly attenuate neurodegener-
ation. The purpose of the exercise-adaptive stress-reversing
exercise was to seek more direct evidence of regulating
mRNA in related pathways, thereby identifying the biolog-
ical functions of genes that regulated the key interpretable
motor-adapted mechanisms of action. We found the adap-
tive mechanism of regular aerobic exercise delaying the
development of neurodegenerative diseases and lesions was
to initiate miR-3557 and miR-324 to regulate one of its
target Ca2+/calmodulin dependent protein kinase (CaMKs)
signaling pathways and to coordinate with regulating closely
related phosphatidylinositol-3-kinase (PI3K)/ protein kinase
B(Akt) /mammalian target of rapamycin (mTOR) path-
way protein expression, hence delaying the progression of
neurodegeneration or alleviating the development of PD
lesions.
2. Materials and Methods
2.1. Experimental Animals, Ethics Statement, and
Exercise Protocol
2.1.1. Experimental Animals and Ethics Statement. Specific-
pathogen-free 13-month-old male Sprague–Dawley rats (n =
40, 549.50±16.13 g) were supplied by the Animal Center of
East Biotechnology Services Company (Changsha, Hunan,
China; License number: Xiang SCXK 2009-0012). Four or
five rats were housed in one standard cage (three or four
rats/cage) with free access to food and water. All animals
were kept in an air-conditioned room maintained at a
constant temperature of 20∘C–25∘C with a relative humidity
of 45%–55%.They were subjected to a cycle of 12-h light and
12-h darkness. They were acclimated to laboratory conditions
for 1 week, prior to the start of the experiment. A total of 40
rats were randomly assigned to 2 groups: sedentary control
PD group (SED-PD, n = 18) and aerobic exercise PD group
(EX-PD, n = 22). After 8 weeks of aerobic exercise in EX-
PD, the SED-PD and EX-PD groups were administered a
unilateral injection of 6-OHDA and the no-lesion side (N)
and the lesion side (L) were formed, respectively.
All animal procedures were approved by the local ethics
committee (the Institutional Review Board of HunanNormal
University) and the Guidelines for Care and Use of Labo-
ratory Animals (Washington DC 2011). Disposal of animals
was done in accordance with The Guidance on the Care of
Laboratory Animals.” (The provisions were issued in 2006
by the Ministry of Science and Technology of the People’s
Republic of China.)
2.1.2. Exercise Protocol. Recently, da Costa and Tuon et al.
[13, 14] corroborated that aerobic treadmill exercise before
unilateral intrastriatal 6-OHDA injection rescued motor
deficits, measured by the apomorphine-induced rotational
asymmetry in rats. We performed regular aerobic exercise
before unilateral intrastriatal 6-OHDA injection in accor-
dance with newfangled researches [13, 15–17] and exercise
load standards reference to Bedford et al. [18]. All animals in
the SED-PDandEX-PDgroupswere first subjected to a 5-day
adaptation period on a rat treadmill (slope gradient 0%, ZH-
PT-1 Treadmill, Li Tai Bio-Equipment Co., Ltd, Hangzhou,
Zhejiang, China). Adapted training was carried out at a speed
of 10 m/min and a gradient of 0∘, for a gradually increasing
duration of time: 10 min on the 1st day, 20 min on the 2nd
day, and 25 min on the 3rd-5th day. During this period, they
were placed on a belt facing away from the electrified grid
(0.6-mA intensity) once per day.
For the actual experiment, SED-PD was in habitual
sedentary behavior, but the EX-PD group underwent daily
training by running at 15 m/min, equivalent to approx.
50%–60% maximum oxygen consumption (V̇O2max) [18,
19], on a slope of 0∘ for a duration of 15 min. During the
first week at the start of the training, the exercise duration
was increased gradually from 15 min to 20 min in the
second week, 25 min in the third week, 30 min in the fourth
week, and 35 min in the fifth and sixth weeks. The EX-PD
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group underwent daily training by running at 20 m/min
and maintained speed for a week (equivalent to approx.
65%–70%V̇O2max) [18] on a slope of 0∘ for a duration of 40
min in the seventh to the eighth weeks. The acceleration of
the treadmill was set such that the final speed of 22 m/min
was achieved in about 3 min after the start of the training.
Sound stimulation and a small wooden stick were used to
stimulate the animals’ tails, when necessary, to ensure that
the animals completed the exercise regime. Also, electrical
stimulation (0.6 mA intensity) was used to keep the rats at
a one-third distance on the treadmill runway. The rats were
required to perform the training 5 days a week for a total of 8
weeks.
2.2. Model of PD Induced by 6-OHDA in Rats. All surgical
procedures were completed and performed under anesthesia,
injected intraperitoneally with 10% chloral hydrate at 3
mL/kg body weight. All efforts were made to minimize the
rats’ suffering and distress. The EX-PD group fasted for
24 h after eight weeks of regular aerobic exercise, and the
rats in SED-PD were carried out in the same way after
eight weeks of habitual sedentary behavior. After anesthesia,
the brains of the rats were fixed on the brain stereotaxic
instrument. The skin was cut and treated with sterilization
to expose the anterior skull, and the intersection between
the anterior ridge and the midline was determined to be
zero in coordinates. Referring to the George Paxinos and
Charles Watson’s original (Zhuge Qiyin) rat brain stereotaxic
map, the right striatum dual coordinates were determined:
the first target, 1.0 mm anterior to the anterior ridge, 3.0 mm
to the right of the midline, 7.0 mm subdurally; the second
target, 0.2 mm posterior to the anterior ridge, 2.6 mm to
the right of the midline, and 6.0 mm subdurally. Triangular
needleswere labeled, and thewellswere drilled. Eachwell was
pipetted with 5.0 𝜇L of 6-hydroxydopamine (6-OHDA, total
40𝜇L, 4.0 𝜇g/𝜇L) to inject the aforementioned two targets.
6-OHDA was dissolved in 0.9% sodium chloride, and 0.2
mg/mL ascorbic acid was dissolved in 0.9% sodium chloride.
The injection rate was 0.50 𝜇L/min. Each point was injected
for 10 min. After the injection, the needle was retained for
5 min and then withdrawn at a speed of 1.0 mm/min. After
the injection, the wound was sealed with bone wax, the head
skin was sutured, and the local skin was routinely disinfected.
At the same time, each rat was injected with clindamycin
intraperitoneally twice a week to prevent infection, and the
cage was normally reared. Behavioral rotation test, tyrosine
hydroxylase (TH), and 𝛼-synuclein was detected to test the
PD model induced by 6-OHDA in rats.
2.3. Behavioral Identification on Rat PD Model. In the first
postoperative week, the rats were placed in a plastic circular
tube with a diameter of about 28 cm and a height of 25 cm
or more. Before each rat was placed, alcohol was disinfected
and deodorized, and then 0.50mg/kg body weight of rats was
given using apomorphine hydrochloride.The intraperitoneal
injection was used to induce the rotation to the contralateral
side, and the number of rotations of the rat to the contralateral
side was recorded. Each measurement lasted 40 min. The
number of rotations in the first-10min, second-10min, and
third-10min were recorded, once per week; more than seven
rotations per minute was the success model [20].
2.4. Tissue Specimen Collection and Analysis. The rats were
anesthetized with chloral hydrate (400 mg/kg, intraperi-
toneally) and decapitated in two weeks after 6-OHDA injec-
tion and lesion maturation [21, 22]. The striatum (Stereotaxic
Atlas of the Rat Brain; George Paxinos., 2005) was dissected
from all rats. Tissue samples were stored at −80∘C until ready
to be used for miRCURY LNA miRNA Array and real-time
fluorescence quantitative PCR. All surgical procedures were
performed under anesthesia induced using chloral hydrate.
All efforts were made to minimize suffering and distress in
animals.The striatum tissue was quickly separated.The tissue
block was cut into cubes of 3 × 3 mm2 with a razor blade,
placed in a precooled 2.5% glutaraldehyde solution (Reagent
Grade, Ameresco, BioOhio, USA.) in a centrifuge tube, and
kept in a refrigerator at 4∘C for electron microscopy.
At least three rats from each group were used for the sam-
ple preparation. After the ascending aorta was infused with
physiological saline, it was perfused with 4% paraformalde-
hyde (PFA)/0.1M phosphate buffer saline (PBS, pH 7.4, 4∘C,
400–500 mL) until the animal’s liver hardened and the tail
was stiff, which indicated the completion of the perfusion.
The brains were isolated and kept in a 4% PFA/ 0.1M PBS
overnight at 4∘C (no more than 48 h). The following day,
they were transferred to 30% sucrose and dehydrated to a
low level. They were routinely dehydrated, cleared, waxed,
and paraffin embedded. The first slice was sectioned from 1.0
mm anterior to the anterior ridge in the right half brain for
immunohistochemical staining.
2.5. Scanning Electron Microscopy (SEM). The rat brain stria-
tum tissues were rapidly dissected, mounted on toothpicks
at resting length, and placed in 2.5% glutaraldehyde in PBS
for overnight fixation at 4∘C. Postfixation was performed in
aqueous 1% osmium tetroxide for 60 min. Specimens were
dehydrated with ethanol sequentially 30%, 50%, 70%, 80%,
90%, and 100% ethanol (twice). Ethanol was removed and
a 1:1 mixture of isoamyl acetate and ethanol was added,
and they were mixed by shaking 10-20 min, and the mix-
ture was discarded and then slowly infiltrated with epoxy
resins (Embed 812/Araldite, Electron Microscopy Sciences,
Hatfield, PA, USA.), embedded, and then heated overnight
at 60∘C. For SEM, the specimens were critical point dried,
mounted on aluminum stubs, sputtered with a gold coat, and
examined under a JEOL 6335F field emission gun scanning
electron microscope.
2.6. Immunohistochemical Staining of TH and 𝛼-Synuclein.
5𝜇m slices were sectioned by 820 Rotary Tissue Slicer (AO
Company, American). Supersense Immunohistochemistry
Detection System Kit (No.BS13278, Bioworld Technology,
Inc., St Louis Park, USA.) was used for the localization,
characterization, and quantification of TH and 𝛼-synuclein
in the striatum. The primary antibody anti-TH (NO.BS4010,
1:200, Bioworld Technology) and anti-𝛼-synuclein (∼20 kD
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NO.BS3429,1:200, Bioworld Technology) were added to each
sample 50 𝜇l/slice, and kept in the refrigerator at 4∘C
overnight. The secondary antibody 50𝜇l/slice of Goat anti-
Rabbit IgG (H&L)-HRP (1:2000, NO.BS13278, Bioworld
Technology) was added dropwise to each sample. Then the
routine steps were diaminobenzidine staining, hematoxylin
and eosin restaining, dehydration with gradient alcohol, and
clearing of tissue sections with xylene.
The morphometric analysis was performed using the
Image-Pro Plus (IPP) Version 6.0 software (Media Cyber-
netics, Inc., Rockville, USA.). Five images were taken using
Compix Simple PCI (Compix, Inc., Imaging Systems, Penn-
sylvania, USA.). Five fields were randomly selected under
eachmicroscope (×200) for analysis.The immunohistochem-
ically positive anti-TH and anti-𝛼-synuclein were stained
yellow or brown by 3,3-diaminobenzidine tetrahydrochloride
(DAB) (Zhongshan Biotechnology Co., Ltd., Beijing, China).
Their integrated optical density (IOD) was evaluated using
the area of interest method in Image-Pro Plus Version 6.0
(IPP 6.0).
2.7. Determination of miRNA Genomics
2.7.1. miRCURY LNA miRNA Array. The seventh generation
of miRCURY LNAmiRNA array (v.18.0) (Exiqon, Denmark)
contained 3100 capture probes, covering all human, mouse,
and ratmiRNAs annotated inmiRBase 18.0, and all viralmiR-
NAs related to these species [23]. This array also contained
capture probes for 25 miRPlus human miRNAs. These were
proprietary miRNAs not found in miRBase.
2.7.2. RNA Extraction. About 60 mg of rat striatum was
used extracting total RNA with TRIzol reagent (Invitro-
gen, Carlsbad, California, USA.) and miRNeasy mini kit
(Qiagen, Germantown, MD, USA.) according to the man-
ufacturer’s protocol, which efficiently recovered all RNA
species, including miRNAs. The RNA quality and quantity
were measured using a NanoDrop spectrophotometer (ND-
1000, NanoDrop Technologies, Wilmington, DE, USA.),
and RNA integrity was determined using gel electrophore-
sis.
2.7.3. miRNA Array. After RNA isolation from the samples,
themiRCURYHy3/Hy5 Power labeling kit (Exiqon,Vedbaek,
Denmark) was used according to the manufacturer’s guide-
line for miRNA labeling. One microgram of each sample was
3’-end-labeled with a Hy3 fluorescent label using T4 RNA
ligase. After the labeling procedure, the Hy3-labeled sam-
ples were hybridized on the miRCURY LNA Array (v.18.0)
(Exiqon, Exiqon A/S, Skelstedet 16, 2950Vedbaek, Denmark)
according to the array manual. The 12-Bay Hybridization
System (Nimblegen Systems, Inc., WI, USA) was used. Then,
the slides were scanned using the Axon GenePix 4000B
microarray scanner (Axon Instruments, CA, USA).
2.7.4. miRNA Array Scanning and Data Analysis. Scanned
images were then imported into the GenePix Pro 6.0 software
(Axon Instruments Inc., Union City, CA, USA) for grid align-
ment and data extraction. Replicated miRNAswere averaged,
and miRNAs with intensities ≥30 in all samples were chosen
for calculating the normalization factor. Expressed data were
normalized using the median normalization. After nor-
malization, differentially expressed miRNAs were identified
using fold change filtering. Finally, hierarchical clusteringwas
performed using the Institute for Genomic Research (TIGR)
Multiple Experiment Viewer (MEV) software (v4.6) to show
distinguishable miRNA expression profiling among samples.
The statistical analysiswas performed using theBioconductor
DESeq package (http://www.bioconductor.org/) to detect
differential expression levels of miRNAs [24].
2.7.5. Bioinformatics Analysis of miRNAs: Target Prediction
and Functional Analysis. All miRNA target data were ana-
lyzed using the Ingenuity Pathway Analysis tool and the
target prediction database in Target Scan. Three aspects of
molecular function, biological process, and cell composition
were obtained through the Gene Ontology analysis.
The miRDB (http://mirdb.org/miRDB/) database was
used to predict the target of the differentially expressed
known miRNAs with a predicted score ≥60. Functional
annotation of each target gene was performed using the
DAVID (the database for annotation, visualization, and inte-
grated discovery) (http://david.abcc.ncifcrf.gov/) bioinfor-
matics resource (version 6.7), including an integrated biolog-
ical knowledge base and analysis tools. Biological significance
was systematically extracted from large gene/protein families.
The information about metabolism, genetic information
processing, environmental information processing, cellular
processes, and human diseases can be obtained from the
database of the Kyoto Encyclopedia of Genes and Genomes
(KEGG) website.
2.8. Real-Time Fluorescence Quantitative Polymerase Chain
Reaction of miRNAs and mRNAs. Real-time fluorescence
quantitative (q) polymerase chain reaction (qPCR) was per-
formed as previously described [25]. At least three samples
were randomly assigned to each group, and qPCR was per-
formed on each of the samples (Table 1). The data regarding
the amplification curves and melting curves of quantitative
real-time PCR and cycle threshold (Ct) values of each gene
mRNA were recorded. The mRNA expression of the target
gene was quantitatively determined using the method of 2-
delta Ct as the internal reference.
2.9. Statistical Analysis. Data were presented as mean ± SEM.
Statistical analysis was performed using predictive analytics
software statistics 16.0 (SPSS Inc., Chicago, IL, USA). The
experimental groups were compared using ANOVA with
repeated measures on the behavior test. A Tukey post-hoc
test was used to follow up with significant ANOVA results.
Cohn’s D was used to examine the effect size. The statistical
significance of the effects of the experimental treatment was
determined by comparing the areas under the curve (P < 0.05,
Student’s t-test).
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Table 1: Real-time fluorescence quantitative PCR primers for target miRNAs and mRNAs.
Gene Sequence (5󸀠—3󸀠)
miRNA reference primers GeneCopoeia, Inc, USA. Catalog#:RmiRQP9003
rno-miR-3557-3p GeneCopoeia, Inc, USA. Catalog#:RmiRQP1817




Camk 2a GeneCopoeia, Inc, USA. Catalog#:
RQP049239
Camk V GeneCopoeia, Inc, USA. Catalog#:
RQP050747
Vdac1 GeneCopoeia, Inc, USA. Catalog#:
RQP051105
Itpr1(PI3R) GeneCopoeia, Inc, USA. Catalog#:RQP045271
Akt1 GeneCopoeia, Inc, USA. Catalog#:RQP051482
mTOR GeneCopoeia, Inc, USA. Catalog#:RQP050125
UCH-L1 GeneCopoeia, Inc, USA. Catalog#:RQP049756
Table 2: Rotation experiment in the PD model (unit: number of turns).
Groups Injection of apomorphine in the first postoperative week Injection of apomorphine in the second postoperative week
The first-10min The second-10min The third-10min The first-10min The second-10min The third-10min
SED-PD 8.00±2.00 7.29±1.30 7.29±1.29 7.75±1.49 8.50±1.05 8.00±1.32
EX-PD 5.63±1.55 6.20±1.19 6.25±1.58 7±1.40 7.6±1.08 6.8±1.16
SED-PD is the sedentary control PD group; EX-PD is the aerobic exercise PD group
3. Results
3.1. Behavioral Test on Rat PD Model. The successful estab-
lishment of the 6-OHDA-induced PD model was confirmed
by the rotation test using an intraperitoneal (IP) injection of
apomorphine hydrochloride [13, 14]. Four rats in SED-PD
and six rats in EX-PD were excluded after the first rotation
test (less 4 rotations). Table 2 shows that the number of
rotations in the EX-PD group was significantly reduced but
not statistically significant compared to the SED-PD group
in the first and the second week after surgery (𝑃 > 0.05).
3.2. Scanning Electron Microscopy of Rat Striatum in the PD
Model. As shown in Figure 1, the striatum showed fewer
neuro-villi and the arrangement was sparse and cluttered in
the no-lesion side of SED-PD at 5000-foldmagnification. The
image at 10,000-foldmagnification revealed the neuronal villi
grown in a scattered pattern with no entangled plexus and
more nodular synaptic junctions on or between the neuronal
villi. The image at 3000-fold magnification revealed atrophy
of the neuronal villi in the lesion side of SED-PD. A large
number of neurites and axons were seen, which were unclear
and resembled a scum-like structure.
Figure 1 shows a larger number of nerve villi in the
striatum arranged neatly in bundles. Many nodules of synap-
tic junctions were observed on or between the neuronal
villi at 5000-fold magnification in the no-lesion side of EX-
PD. Atrophy of the neuronal villi and a large number of
neurites and axonswere observed in the striatum at 3000-fold
magnification in the lesion side of EX-PD. The neurites and
axons were entangled in bundles and neatly arranged. Many
neuronal villi were observed to be entangled with the neurites
and axons. The image at 10,000-fold magnification revealed
that the neurites and axons were thick, and still more nodular
synaptic connections were found above or between neuronal
villi. Our results showed the neurons, axons, and neuronal
villi of the striatum were clearly and tightly arranged, and
neurons and axons were significantly larger in the EX-PD
group compared to the SED-PD group.
3.3. TH and 𝛼-Synuclein Expression in the Rat Striatum.
𝛼-Synuclein protein aggregation was the major structural
component of the intracellular protein inclusions termed
Lewy bodies that define the hallmark of PD [26]. And
TH expression decreased in the striatum is another marker
involved in the pathology of PD [27]. Immunohistochemical
6 BioMed Research International
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Figure 1: Scanning electron microscopy images of the striatum of the rat model of PD. SED-PD, the sedentary control PD group; EX-PD, the
aerobic exercise PD group; no-lesion side (N) and lesion side (L).
staining of TH and 𝛼-synuclein protein was abundantly
expressed in the cytoplasm of the striatum and sparingly
expressed in the stroma as a brownish color, with a small
number of nuclei also tan and normal nuclei stained blue. TH
and 𝛼-synuclein positively stained area were large, and the
protein stained dark in color in the striatum in SED-PD and
EX-PD. Compared with the no-lesion side, TH expression
was decreased significantly in the lesion side in both SED-
PD and EX-PD groups (𝑃 < 0.01); but compared to the
SED-PD group, TH expression was significantly increased
in EX-PD preexecuted with regular aerobic exercise (𝑃 <
0.01) (Figure 2). Compared to the no-lesion side, 𝛼-synuclein
expression in the lesion side significantly increased in the
striatum in SED-PD and EX-PD (𝑃 < 0.01). Intriguingly,
compared to the SED-PD group, 𝛼-synuclein was signifi-
cantly decreased in EX-PD (𝑃 < 0.01) (Figure 2).
3.4. Effect of Differentially Expressed miRNAs in the Striatum
of the Rat Model of PD. Based on the preimplementation
of regular aerobic exercise and the impact of miRNAs
on PD-related expression profiles, this study standardized
and screened the unreliable data and screened 11 miRNAs
upregulated by regular aerobic exercise to two-fold or higher
(multifold) in the striatum of the rat model of PD: miR-
1-3p, miR-34c-3p, miR-31a-3p, miR-499-3p, miR-200b-5p,
miR-465-3p,miR-190a-3p,miR-146a-3p,miR-2985,miR-377-
3p, and miR-3557-3p (Table 3). Further, 10 miRNAs were
downregulated by twofold or more: miR-136-5p, miR-138-
5p,miR-324-5p, let-7e-3p,miR-770-5p,miR-134-5p,miR-935,
miR-653-3p, miR-331-5p, and miR-539-3p (Table 3).
The bioinformatics analysis was performed on the afore-
mentioned 21 miRNAs: target prediction and functional
analysis. The subcellular localization, the role of target genes
in known diseases, and pathway screening of the target gene
pairs were investigated according to the expression level.
The reliable miRNA-mRNA interaction network was selected
from the target database by predicting transcription factors
and molecular activity. miR-3557 and miR-324 were worth
further exploration in this experiment.
3.5. Differential Screening of miR-3557 and miR-324
3.5.1. Gene Ontology (GO) and KEGG Biological Pathway
Analysis. According to the GO bioinformatics analysis, miR-
3557 and miR-324 had molecular functions. The analysis
showed that 218 targeted genes were involved in energy
metabolism, 42 in metabolic regulation, 44 in developmental
processes, 75 in biological regulation, and 64 in stimulus
response. Gene-related biological functions were regulation
of sensory and pain perception, integration of regulatory sig-
naling pathways, phosphatidylinositol metabolic processes,
positive regulation of biological processes, and positive reg-
ulation of transmembrane transporter activity.
miR-3557-3p is closely related to CaMKV, nuclear het-
erogeneous riboproteins; and miR-324 is closely related to
Vdac1. The KEGG biological pathway analysis predicts
possible enrichment of biological pathways and classifies the
results with statistical significance. These statistically sig-
nificant biological pathways include the calcium signal-
ing pathway (rno04020), neuroactive ligand-receptor inter-
action (rno04080), DNA replication (rno03030), extracel-
lular matrix- (ECM-) receptor interaction (rno04512),
amphetamine addiction (rno05031), glycosylphosphatidyl-
inositol- (GPI-) anchor biosynthesis (rno00563), B cell
receptor signaling pathway (rno04662), endocytosis
(rno04144), drug metabolism-cytochrome P450 (rno00982),
and nucleotide excision repair (rno03420). These biological
signaling pathways may have a statistically significant
relationship with PD.
3.5.2. Validation of miR-3557 and miR-324. The analysis of
target genes showed that miR-3557was upregulated andmiR-
324was downregulated. Real-time quantitative PCRwas used
to verify the consistency of the results of miRNA expression
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Figure 2: TH and 𝛼-synuclein expression in the striatum of the PD rat model. (A) Microscopic image of TH; (B). Microscopic image of 𝛼-
synuclein; SED-PD is the sedentary control PD group, EX-PD is the aerobic exercise PD group; ∗∗Ρ < 0.01, comparing between SED-PD and
EX-PD; ##Ρ < 0.01, comparing between no-lesion side (N) and lesion side (L), n=4-6; no-lesion side (N) and lesion side (L); TH, tyrosine
hydroxylase.
andmicroarray.The expression of miR-3557was significantly
upregulated in the EX-PD group compared to the SED-
PD group (𝑃 < 0.01) (Figure 3). Further, the expression
of miR-3557 was significantly downregulated in Lesion side
compared to no-lesion side in EX-PD (𝑃 < 0.05).
Figure 3 also shows that the expression of miR-324 was
significantly downregulated in the lesion side of EX-PD
group compared to the SED-PD group (𝑃 < 0.01), but the
expression of miR-324 was slightly downregulated in the
lesion side compared to the no-lesion side in SED-PD. The
expression of miR-324was significantly downregulated in the
lesion side compared to the no-lesion side in EX-PD (𝑃 <
0.05).
3.6. Effect of CaMKs/mTOR Signaling Pathway in the Striatum
of the RatModel of PD. Figure 4 shows thatCamk2𝛼, CamkV,
andVdac1mRNA expression was significantly upregulated in
the lesion side compared to the no-lesion side in SED-PD and
EX-PD (𝑃 < 0.01). CamkV and Vdac1mRNA expression was
downregulated in the lesion side of EX-PD compared with
the SED-PD (𝑃 < 0.01), butCamk2𝛼was slightly upregulated.
Intriguingly, Camk2𝛼 and CamkV mRNA expression was
also downregulated in the no-lesion side of EX-PD compared
with the SED-PD, and Vdac1 significantly downregulated
(𝑃 < 0.01).
The real-time quantitative PCR analysis showed that
PI3R, Akt, and mTOR mRNA expression (Figure 4) was
significantly upregulated in the lesion side compared to the
no-lesion side in SED-PD (𝑃 < 0.01) and EX-PD group except
Akt1 (𝑃 < 0.01). PI3R, Akt, and mTOR mRNA expression
was downregulated in the no-lesion side of EX-PD compared
to SED-PD. However, PI3R and mTOR mRNA expression
was slightly upregulated in the lesion side of EX-PD group
compared to the SED-PD group, but the expression of Akt1
was significantly downregulated (𝑃 < 0.01). In summary,
regular aerobic exercise activated the effect of PI3R and
mTOR mRNA expression.
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Table 3: Differential miRNAs in the striatum of the rat model of PD on regular aerobic exercise.
ID Gene log2 fold change P-value
More than two-fold upregulated miRNAs
14294 rno-miR-1-3p 6.5784 P <0.01
42767 rno-miR-34c-3p 3.6394 P <0.05
46320 rno-miR-31a-3p 4.3727 P <0.01
145692 rno-miR-499-3p 10.8036 P <0.01
145974 rno-miR-200b-5p 7.3004 P <0.01
148207 rno-miR-465-3p 2.2084 P <0.05
148330 rno-miR-190a-3p 3.0857 P <0.05
148365 rno-miR-146a-3p 3.4221 P <0.05
148439 rno-miR-2985 3.9897 P <0.05
148549 rno-miR-377-3p 3.1776 P <0.05
148581 rno-miR-3557-3p 21.2246 P <0.01
More than two-fold downregulated miRNAs
10943 rno-miR-136-5p 0.5312 P <0.01
13140 rno-miR-138-5p 0.5830 P <0.01
42477 rno-miR-324-5p 0.4613 P <0.05
42743 rno-let-7e-3p 0.4045 P <0.01
42817 rno-miR-770-5p 0.4294 P <0.01
42942 rno-miR-134-5p 0.5081 P <0.05
145742 rno-miR-935 0.4532 P <0.05
148174 rno-miR-653-3p 0.1252 P <0.01
148385 rno-miR-331-5p 0.3686 P <0.05























































Figure 3:MiR-3557 and miR-324 expression by real-time quantitative PCR assay. ∗∗𝑃 < 0.01, comparing between SED-PD and EX-PD; #𝑃 <
0.05, comparing between no-lesion side (N) and lesion side (L); SED-PD is the sedentary control PD group, EX-PD is the aerobic exercise
PD group.
3.7. Effect of Downstream Molecules in the Rat Model of
PD. U-ubiquitin C-terminal hydrolase 1 (UCH-L1) mRNA
expression (Figure 5) was significantly upregulated in the
lesion side compared to the no-lesion side in SED-PD and
EX-PD (𝑃 < 0.01). However, UCH-L1mRNA expression was
significantly downregulated in the no-lesion side in EX-PD
compared to SED-PD (𝑃 < 0.05). But, intriguingly, UCH-
L1 mRNA expression was upregulated in the lesion side of
the EX-PD group compared to the SED-PD group (𝑃 <
0.01).
4. Discussion
Exercising both before and after 6-OHDA could maximize
and improve the possibility of motor function by exercise-
induced improvements in PD rats [15, 28, 29]. Increasing




































































































































































Figure 4: Expression levels of CaMKs/mTOR signal related mRNA by real-time quantitative PCR assay. ∗∗𝑃 < 0.01, comparing between SED-
PD and EX-PD; #𝑃 < 0.05, ##𝑃 < 0.01, comparing between no-lesion side (N) and lesion side (L); SED-PD is the sedentary control PD group,

























Figure 5: Expression levels of UCH-L 1 mRNA by real-time quantita-
tive PCR assay. ∗𝑃 < 0.05, ∗∗𝑃 < 0.01, comparing between SED-PD
and EX-PD; ##𝑃 < 0.01, comparing between no-lesion side (N) and
lesion side (L); SED-PD is the sedentary control PD group, EX-PD
is the aerobic exercise PD group.
aerobic treadmill exercise before unilateral intrastriatal 6-
OHDA injection has been shown to rescue motor deficits,
measured by the apomorphine-induced rotational asymme-
try in rats [13, 14]. In this study, regular aerobic exercise before
unilateral intrastriatal 6-OHDA injection improved the PD
rat’s behavior and saved the structure of striatum in PD
rat from scanning electron microscopy observation. Regular
aerobic exercise significantly increased TH expression and
decreased 𝛼-synuclein expression. Our experimental results
provided evidence that regular aerobic exercise alleviated
the neurodegenerative process of PD lesions. The specific
mechanism of exercise effects is still unclear.
MiRNAs act on many targeted genes involved in the
development of neurological diseases or neurodegenerative
diseases. Hua et al. [30] discovered more than 30 specific and
highly expressed miRNAs in rat neural tissue and speculated
that these miRNAs with specific high expression in rat
neural tissue might help in the diagnosis and treatment of
neurological diseases. Rogaev et al. [31] found that miRNAs
were involved in the occurrence of many neuropsychiatric
disorders, especially those associated with developmental
abnormalities. Yet, no known study has examined how
the miRNAs (examined via miRNAs profiling) might differ
between PD animals who regularly exercise interventions and
PD animals who are habitually sedentary. We further found
that 11 miRNAs, such as miR-3557-3p, were upregulated by
twofold or more in the striatum of rats with PD on the
preimplementation of regular aerobic exercise. And we also
found 10 miRNAs, such as miR-324-5p, were downregulated
by twofold or more. Feng et al. [32] found upregulation of
rno-miR-3557-5p could be seen as biomarkers of prognosis in
clinical therapy of heart failure. Diaz et al. [33] found that the
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overexpression of miR-324-3p promoted the dysregulation of
the expression of genes involved in cell death and apoptosis,
cAMP and Ca2+ signaling, cell stress, and metabolism. In
summary, the subcellular localization, the role of target genes
in known diseases, and pathway screening of the target gene
pairs were investigated according to the expression level in
this study. Also, the most reliable miRNA-mRNA interaction
network was screened by predicting transcription factors and
molecular activity. The results showed that miR-3557 and
miR-324 deserve further exploration.
The bioinformatics analysis showed that miR-3557-3p
was closely related to CaMKV, nuclear heterogeneous ribo-
proteins, and macro-related proteins; miR-324 was closely
related to Vdac1. The KEGG biological pathway analysis
predicted the possible enrichment of biological pathways,
including calcium signaling pathways, stimulated nervous
system interactions with receptors, and DNA replication
pathways. CaMKs is highly expressed in neurons and has
a specific subcellular localization. It converts intracellularly
elevated calcium signals into a range of target proteins,
including ion channels and transcriptional activators, and
regulates synaptic transmissions related to the downstream
signaling pathway [34, 35]. Firstly, CaMKs regulate synaptic
plasticity and neurotransmitter release. Zhu et al. [36] showed
that CaMKs could activate TH. TH is a rate-limiting enzyme
that catalyzes tyrosine to form dopa. After dopa forma-
tion, it can be further transformed into neurotransmitters
norepinephrine and DA. Phosphorylated TH can increase
the synthesis of catecholamines. CaMKs can also directly
promote DA release. Secondly, CaMKs play a vital role in
the Ca2+/CaM signaling system, different concentrations and
subcellular regions of Ca2+ activate a range of substrates of
CaMK2, or PP1 (Ser/Thr phosphatase), which appears to be
critical in controlling CaMKs-dependent neuronal signaling
[37].
CaMKs pathways are involved in many upstream signal-
ing pathways, such as growth factor signaling, PI3K/Akt, and
calcium signaling pathway [38]. mTOR is a serine/threonine
protein kinase that serves as the site of energy-sensitive path-
ways for PI3K/Akt and serine/threonine kinase II [39].mTOR
not only regulates cell proliferation and survival but also
participates in membrane transport and protein degradation,
especially in the regulation of protein translation levels.
Recently, mTOR has been shown to promote autophagy,
remove abnormal proteins such as amyloid polypeptide
in AD and mutated 𝛼-synuclein in familial PD, and thus
treat related diseases [40]. This provides a new treatment
strategy for preventing and treating geriatric diseases. Our
results showed that PI3R and mTOR mRNA expression was
slightly upregulated in the lesion side in EX-PD compared
with the SED-PD group and showed that regular aerobic
exercise improved the effect size of PI3R and mTOR mRNA
expression. This indicated that preregular aerobic exercise
induced the activation of mTOR signaling pathway and
regulating to remove abnormal proteins mutated 𝛼-synuclein
in the PD model rat striatum. Ankovic [41] reported that
mTOR had the potential to treat PD. Pan et al. [42] found that
the autophagy inducer rapamycin, specifically targeting the
autophagy-gated mTOR, could alleviate this phenomenon.
Inhibition of autophagy exacerbated the accumulation of
𝛼-synuclein leading to cell death, rapamycin-induced the
degradation of 𝛼-synuclein and cell survival.
The secretion and expression of UCH-L1 could be
involved in the pathology of Parkinson’s disease. Lowe et al.
[43] reportedmutations in 𝛼-synuclein and UCH-L1 genes in
familial PD and the presence of these proteins in Lewy bodies
of sporadic PD, indicating errors in the production of these
proteins during folding and degradation, which could cause
nerve cell degeneration. Mandel et al. [44] found the increase
in the UCH-L1 level is favorable for DA neurons to clear
abnormal proteins, delay the accumulation of abnormal pro-
teins, and inhibit the formation of Lewy bodies. Manago et
al. [45] found that UCH-L1 increased ATP-induced currents
were dependent on cAMP-dependent protein kinase (PKA)
and CaMK2. Zhang et al. [46] reported that conventional
protein kinase C (cPKC) could regulate oxidative stress and
apoptosis through UCH-L1; inhibiting UCH-L1 expression
can negatively regulate autophagy through the extracellular
signal-regulated kinase (ERK)-mTORpathway.We found the
expression of UCH-L1 mRNA expression was upregulated
in the lesion side of EX-PD group compared with SED-
PD group. It is shown that preregular aerobic exercise also
activated the expression of UCH-L1 in the PD lesions. Our
results indicated that regular aerobic exercise alleviated the
neurodegenerative process of PD lesions by improving UCH-
L1 level, whichmight be the downstream of CaMKs ormTOR
signal regulation. Kanthasamy et al. [47] found that ROS and
oxidative damage were involved in the disease process of PD.
UCH-L1 could effectively remove ROS and protect neurons
from oxidative damage. Therefore, UCH-L1 reflects the self-
protection mechanism of neurons in experimental animals.
Whether the change in the UCH-L1 level can inhibit the
occurrence or development of PD lesions on aerobic exercise
may be worth further exploring.
5. Conclusions
The adaptive mechanism of regular aerobic exercise delaying
the development of neurodegenerative diseases and lesions
was that miR-3557/324 was activated to regulate one of
its targets CaMKs signaling pathways. CaMKs coordinated
with mTOR pathway-related gene expression and improved
UCH-L1 level to favor for tyrosine hydroxylase and clear
abnormal 𝛼-synuclein, thereby delaying neurodegeneration
or improving the pathogenesis of PD lesions. This study
provided important evidence and theoretical guidance for
motor rehabilitation.
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